Rising obesity strains Europe's shrinking health budgets (Reuters, 16 November 2012)

Teenagers urged to exercise to ward off bone disease (EurekAlert, 16 November 2012)

Sanofi diabetes treatment Lyxumia wins EU panel recommendation (Bloomberg Businessweek, 16 November 2012)

19 Nov 2012

The European Medicines Agency has issued a positive recommendation for the marketing application of Sanofi's GLP-1 analogue Lyxumia (lixisenatide) for the treatment of type 2 diabetes mellitus.

Related Topics

Adrenal Diabetes Metabolism Obesity Cardiovascular Bone Endocrine-Disrupting Chemicals Endocrine-Related Cancer Neuroendocrinology Reproduction Steroid and Steroidogenesis Thyroid

Share this story

Top stories

Call for nominations for Awards Committee Chair
30 Oct 2024

James M Tanner Award - 2025 nominations open
30 Oct 2024

Would you like to host the BSPED annual meeting?
21 Oct 2024

Most read